Please assess the completion status of the following clinical trial:

Trial Title: Galantamine Effects on Cognitive Function in Abstinent Cocaine Users

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and females, between the ages 21 and 50~* Fulfill criteria for past cocaine dependence~* No cocaine use for the past 30 days~* No other current dependence or abuse of other drugs or alcohol~* No current medical problems and normal ECG~* Not pregnant,nor breast feeding,~* Using acceptable birth control methods.~Exclusion Criteria:~* Current major psychiatric illness including mood, psychotic or anxiety disorders~* History of major medical illnesses; including asthma or chronic obstructive lung disease, history or current gastrointestinal ulcer, hepatic or renal impairment and cardiac rhythm disturbances~* Use of other medications including,drugs that slow heart rate~* Known allergy to galantamine

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Galantamine 8 mg/day (Type: ACTIVE_COMPARATOR): Galantamine 8 mg/day
- Placebo (Type: PLACEBO_COMPARATOR): placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).